Years I'm sure. Lympro's advantage will be first to market.
There is, however, a few competitors developing AD blood tests hot on our heels.
The quicker Lympro is commercialized, the better. Delays might be costly.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links